SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-23-044636
Filing Date
2023-09-21
Accepted
2023-09-20 17:43:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ny20010987x1_s3.htm S-3 231040
2 EXHIBIT 5.1 ny20010987x1_ex5-1.htm EX-5.1 13101
3 EXHIBIT 23.1 ny20010987x1_ex23-1.htm EX-23.1 1702
4 FILING FEES TABLE ny20010987x1_ex107.htm EX-FILING FEES 56672
5 logo_aquestive-reg.jpg GRAPHIC 39906
6 logo_aquestive-regx1.jpg GRAPHIC 43389
7 ny20010987x1_ex5-1img01.jpg GRAPHIC 84461
  Complete submission text file 0001140361-23-044636.txt   534319
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274609 | Film No.: 231267312
SIC: 2834 Pharmaceutical Preparations